A computer model and program for xenobiotic disposition during pregnancy

Computer Methods and Programs in Biomedicine

Volumn 53, Issue 3, 1997, Pages 201-224

  Luecke, Richard H ^a   Wosilait, Walter D ^b   Pearce, Bruce A ^c   Young, John F ^c  

^a University of Missouri   (United States)

^b University of Missouri   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Computer model; Drug disposition; Embryo fetus; Human pregnancy; Imipramine; Methyl mercury; Physiological flow model

Indexed keywords

CHEMICALS; COMPUTER SOFTWARE; DATA PROCESSING; MEDICAL COMPUTING; METABOLISM; PARAMETER ESTIMATION; REGRESSION ANALYSIS;

PHARMACOKINETIC MODEL;

COMPUTER SIMULATION;

XENOBIOTIC AGENT;

ARTICLE; COMPUTER MODEL; COMPUTER PROGRAM; DRUG DISTRIBUTION; EMBRYO; FEMALE; FETUS; HUMAN; HUMAN TISSUE; MOTHER FETUS RELATIONSHIP; PHARMACOKINETICS; PREGNANCY; REGRESSION ANALYSIS; XENOBIOTIC METABOLISM;

ANIMALS; COMPUTER SIMULATION; DESIPRAMINE; FEMALE; HUMANS; IMIPRAMINE; MATERNAL-FETAL EXCHANGE; MERCURY; METHYLMERCURY COMPOUNDS; MODELS, BIOLOGICAL; PREGNANCY; RATS; SOFTWARE; XENOBIOTICS;

EID: 0031194811     PISSN: 01692607     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-2607(97)00020-5     Document Type: Article

References (31)

1. K.B. Bischoff, R.L. Dedrick, D.S. Zaharko, J.A. Longstreth, Methotrexate pharmacokinetics, J. Pharm. Sci. 60 (1971) 1128-1133.
2. R.H. Luecke, L.E. Thomason, W.D. Wosilait, Physiological flow model for drug elimination interactions in the rat, Comp. Prog. Biomed. 11 (1980) 88-98.
3. L.E. Gerlowski, R.K. Jain, Physiologically based pharmacokinetic modeling: Principles and applications, J. Pharm. Sci. 72 (1983) 1103-1127.
4. J.W. Fisher, T.A. Whittaker, D.H. Taylor, H.J. Clewell III, M.E. Andersen, Physiologically based pharmacokinetic modeling of the pregnant rat: A multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid, Toxicol. Appl. Pharmacol. 99 (1989) 395-414.
5. E.J. O'Flaherty, W. Scott, C. Schreiner, R.P. Beliles, A physiologically based kinetic model of rat and mouse gestation: Disposition of a weak acid, Toxicol. Appl. Pharmacol. 112 (1992) 245-256.
6. D.O. Clarke, B.A. Elswick, F. Welsch, R.B. Conolly, Pharmacokinetics of 2-methoxyethanol and 2-methoxy-acetic acid in the pregnant mouse: A physiologically based mathematical model, Toxicol. Appl. Pharmacol. 121 (1993) 239-252.
7. K.K. Terry, B.A. Elswick, F. Welsch, R.B. Conolly, Development of a physiologically based pharmacokinetic model describing 2-methoxyacetic acid disposition in the pregnant mouse, Toxicol. Appl. Pharmacol. 132 (1995) 103-114.
8. J.C. Lewis, R.H. Luecke, W.D. Wosilait, Microcomputer program for interactions in drug elimination in the rat, Comput. Methods Prog. Biomed. 26 (1988) 137-143.
9. J.F. Young, W.S. Branham, D.M. Sheehan, M.E. Baker, Wosilait, R.H. Luecke, Physiological 'constants' for PBPK models for pregnancy, J. Toxicol. Environ. Hlth., (1997) in press.
10. R.H. Luecke, W.D. Wosilait, B.A. Pearce, J.F. Young, A physiologically based pharmacokinetic computer model for human pregnancy, Teratology 49 (1994) 90-103.
11. W.D. Wosilait, R.H. Luecke, J.F. Young, A mathematical analysis of human embryonic and fetal growth data, Growth Dev. Aging 56 (1992) 249-257.
12. R.H. Luecke, W.D. Wosilait, J.F. Young, Mathematical representation of organ growth in the human embryo/fetus, Int. J. Bio-Med. Comp. 39 (1995) 337-347.
13. W.D. Wosilait, R.H. Luecke, Displacement interactions resulting from competition for binding sites in proteins, in: R.S. Goldstein, W.R. Hewitt, J.R. Hook (Eds.), Toxic Interactions, Academic Press, New York, 1990, pp. 115-147.
14. A.M. Morshedi, AMMLSQ: Least squares algorithm, Dot Products, Inc., Houston, 1990.
15. Y. Zhu, T. Backx, Identification of Multivariable Industrial Processes, Springer-Verlag, New York, 1993.
16. C. L DeVane, J.W. Simpkins, Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose, Drug Metab. Disp. 13 (1985) 438-442.
17. M.R. Ware, C.L. DeVane, Imipramine treatment of panic disorder during pregnancy, J. Clin. Psychiatry 51 (1990) 482-484.
18. F.F. Farris, R.L. Dedrick, P.V. Allen, J.C. Smith, Physiological model for the pharmacokinetics of methyl mercury in the growing rat, Toxicol. Appl. Pharmacol. 119 (1993) 74-90.
19. S. Kitamura, K. Sumino, K. Hayakawa, T. Shibata, Dose-response relationship of methylmercury, in: G.F. Nordberg (Ed.), Effects and Dose-Response Relationships of Toxic Metals, Elsevier Scientific Publishing Co., Amsterdam, 1976, pp. 262-272.
20. J. Aaseth, A. Wannag, T. Norseth, The effect of N-acety-lated DL-penicillamine and DL-homocysteine thiolactone on the mercury distribution in adult rats, rat foetuses and Macaca monkeys after exposure to methyl mercuric chloride, Acta Pharmacol. Toxicol. 39 (1976) 302-311.
21. J. Sherlock, J. Hislop, D. Newton, G. Topping, K. Whittle, Elevation of mercury in human blood from controlled chronic ingestion of methylmercury in fish, Human Toxicol. 3 (1984) 117-131.
22. S. Skerfving, Methylmercury exposure, mercury levels in blood and hair, and health status in Swedes consuming contaminated fish, Toxicology 2 (1974) 3-23.
23. J.C. Smith, P.V. Allen, M.D. Turner, B. Most, H.L. Fisher, L.L. Hall, The kinetics of intravenously administered methyl mercury in man, Toxicol. Appl. Pharmacol. 128 (1994) 251-256.
24. P. Grandjean, P. Weihe, J.B. Nielsen, Methylmercury: Significance of intrauterine and postnatal exposures, Clin. Chem. 40/7 (1994) 1395-1400.
25. J.R. Leis, M.A. Kramer, The simultaneous solution and sensitivity analysis of systems described by ordinary differential equations, ACM Trans Math. Software 14 (1988) 45-60.
26. C.L. DeVane, Pharmacokinetic correlates of fetal drug exposure, in: M.M. Kilbey, K. Asghar (Eds.), Methodological Issues in Controlled Studies on Effects of Prenatal Exposure to Drug Abuse, NIDA Research Monograph 114, 1991, pp. 18-44.
27. B.A. Pearce, BIO-PREG: Biologically-Based Dose Response Modeling, A Model For Pregnancy, Operations Manual, NCTR, Jefferson, AR, 1996.
28. J.L. Gabrielsson, T. Groth, An extended physiological pharmacokinetic model of methadone disposition in the rat: Validation and sensitivity analysis, J. Pharmacokinet. Biopharm. 16 (1988) 183-201.
29. H.J. Clewell 3rd, T.S. Lee, R.L. Carpenter, Sensitivity of physiologically based pharmacokinetic models to variation in model parameters: Methylene chloride, Risk Analysis 14 (1994) 521-531.
30. M.V. Evans, W.D. Crank, H.M. Yang, J.E. Simmons, Applications of sensitivity analysis to a physiologically based pharmacokinetic model for carbon tetrachloride in rats, Toxicol. Appl. Pharmacol. 128 (1994) 36-44.
31. D. Krewski, Y. Wang, S. Bartlett, K. Krishnan, Uncertainty, variability, and sensitivity analysis physiological pharmacokinetic models, J. Biopharm. Stat. 5 (1995) 245-271.